NIM
BPMC

NEOS Investment Management’s Blueprint Medicines BPMC Stock Holding History

NEOS Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,972
Closed -$1.86M – 617
2025
Q1 		$1.86M Buy
20,972
+3,869
+23% +$377K 0.04% 338
2024
Q4 		$1.49M Sell
17,103
-833
-5% -$76.3K 0.04% 339
2024
Q3 		$1.66M Buy
17,936
+4,438
+33% +$441K 0.05% 293
2024
Q2 		$1.45M Buy
13,498
+8,364
+163% +$837K 0.06% 267
2024
Q1 		$487K Buy
5,134
+150
+3% +$12.9K 0.03% 391
2023
Q4 		$460K Buy
+4,984
New +$323K 0.04% 299

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NEOS Investment Management's BPMC Position: Q2 2025 in Review

NEOS Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 20,972 shares — an estimated $1.86M sold.

NEOS Investment Management first reported a position in BPMC in Q4 2023 and held it in 6 quarters. The position peaked at $1.86M in Q1 2025. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • NEOS Investment Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • NEOS Investment Management sold 20,972 Blueprint Medicines shares in Q2 2025, an estimated $1.86M.
  • NEOS Investment Management first reported a position in Blueprint Medicines in Q4 2023 and held it in 6 quarters.
  • NEOS Investment Management's Blueprint Medicines position peaked at $1.86M in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on NEOS Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.